SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Epilepsy Genes May Cancel Each Other
November 5, 2007
 · 
1 min read
Lone Star Bio
American Heart Association: Six New Circulation Journals Planned for 2008
November 5, 2007
 · 
1 min read
Drug Development
Imaging Identifies Benefits of PCI over Drug Therapy
November 5, 2007
 · 
1 min read
Lone Star Bio
Study Looks at Differences in Drug-Eluting vs. Bare Metal Stents
November 5, 2007
 · 
1 min read
Lone Star Bio
Smaller Heart Pump Bridges Time to Transplant for More Women
November 5, 2007
 · 
1 min read
Lone Star Bio
SUMO Wrestles SENP1 Over Response To Hypoxia, Providing Possible Cancer Targets, M. D. Anderson Cancer Center Study
November 2, 2007
 · 
1 min read
Drug Development
Radio Waves Fire Up Nanotubes Embedded in Tumors, Destroying Liver Cancer
November 2, 2007
 · 
1 min read
BioMidwest
A History of Science Fairs
November 1, 2007
 · 
1 min read
Lone Star Bio
Genes May Predict Disease Progression in AIDS
October 23, 2007
 · 
1 min read
Lone Star Bio
University of Texas Rheumatologists Discover Two Genes Related to Disabling Form of Arthritis
October 22, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Nnamdi Njoku Appointed President of Omnicell
July 1, 2026
 · 
5 min read
Press Releases
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
July 1, 2026
 · 
9 min read
Press Releases
Caris Life Sciences Launches Caris Detect, the World’s Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
July 1, 2026
 · 
6 min read
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
 · 
11 min read
Press Releases
Vizient Forecasts 20% Growth in Outpatient Care, 7% in Inpatient Care
June 30, 2026
 · 
3 min read
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Load More